KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $359 | -48.7% | 39,465 | -40.4% | 0.00% | -50.0% |
Q2 2023 | $700 | -25.7% | 66,176 | -14.1% | 0.00% | 0.0% |
Q1 2023 | $942 | -1.5% | 77,024 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $956 | -100.0% | 77,024 | -45.5% | 0.00% | -60.0% |
Q3 2022 | $1,929,000 | +17.6% | 141,225 | +57.8% | 0.01% | +25.0% |
Q2 2022 | $1,641,000 | +450.7% | 89,487 | +525.8% | 0.00% | +300.0% |
Q2 2021 | $298,000 | -76.6% | 14,300 | -68.3% | 0.00% | -66.7% |
Q1 2021 | $1,275,000 | -48.8% | 45,127 | -40.8% | 0.00% | -50.0% |
Q4 2020 | $2,488,000 | – | 76,180 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |